Company
X
Pharma
BDN
Estimated
Demand
by
year,
country
and
customer,
in
kilogram
CONFIDENTIAL
BUSINESS
INFORMATION
2006­­­­­­­­­­­­­­­­­­­­­­­­­
Shipped­
to
Customer
Product
CFC­
11
CFC­
12
2006­
est
DATA
POINTS
ARE
CONFIDENTIAL
BUSINESS
INFORMATION.
A
COPY
OF
THE
DATA
IS
AVAIL
rams
­­­­­­­­­­­­­­­­­­­­­­­­­­
2007­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­
2008­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­
CFC­
114
Total
CFC­
11
CFC­
12
CFC­
114
Total
CFC­
11
CFC­
12
CFC­
114
ILABLE
IN
THE
CONFIDENTIAL
PORTION
OF
THE
DOCKET
TO
THIS
RULEMAKING
­­­­­­­­­­­­­
2009­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­
2010­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­
Total
CFC­
11
CFC­
12
CFC­
114
Total
CFC­
11
CFC­
12
CFC­
114
Total
Company
X
Pharma
BDN
Shipments
by
year,
country
and
customer,
in
kilograms
CONFIDENTIAL
BUSINESS
INFORMATION
Shipped­
to
Customer
Product
CFC­
11
CFC­
12
2005
DATA
POINTS
ARE
CONFIDENTIA
All
Pharma
BDN
­
2005
total
2004
DATA
POINTS
ARE
CONFIDENTIA
All
Pharma
BDN
­
2004
total
2003
DATA
POINTS
ARE
CONFIDENTIA
All
Pharma
BDN
­
2003
total
2002
DATA
POINTS
ARE
CONFIDENTIA
All
Pharma
BDN
­
2002
total
CFC­
114
Total
TIAL
BUSINESS
INFORMATION.
A
COPY
OF
THE
DATA
IS
AVAILABLE
IN
THE
CONFIDENTIAL
POR
TIAL
BUSINESS
INFORMATION.
A
COPY
OF
THE
DATA
IS
AVAILABLE
IN
THE
CONFIDENTIAL
POR
TIAL
BUSINESS
INFORMATION.
A
COPY
OF
THE
DATA
IS
AVAILABLE
IN
THE
CONFIDENTIAL
POR
TIAL
BUSINESS
INFORMATION.
A
COPY
OF
THE
DATA
IS
AVAILABLE
IN
THE
CONFIDENTIAL
POR
RTION
OF
THE
DOCKET
TO
THIS
RULEMAKING
RTION
OF
THE
DOCKET
TO
THIS
RULEMAKING
RTION
OF
THE
DOCKET
TO
THIS
RULEMAKING
RTION
OF
THE
DOCKET
TO
THIS
RULEMAKING
